<i>MAP2K1</i> ( <i>MEK1</i> ) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking

Abstract

MEK1 mutations define a distinct subset of lung cancers (∼1%) with potential sensitivity to MEK inhibitors. Mutations are predominantly transversions, in keeping with a strong association with smoking.